Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Int J Drug Policy ; 93: 102908, 2021 07.
Article in English | MEDLINE | ID: covidwho-1343193

ABSTRACT

An unprecedented public health crisis confronts the world. Iran is among the hardest-hit countries, where effects of the COVID-19 pandemic are stretched across society and felt by the most marginalised people. Among people who use drugs, a comprehensive response to the crisis calls for broad collaboration, coordination, and creativity involving multiple government and non-government organisations. This commentary provides early insights into an unfolding experience, demonstrating the operational and policy impact of an initiative, bringing together a diverse array of harm reduction stakeholders to address the pandemic. In the context of lived experiences of social and economic marginalization, this initiative intends to lead efforts in developing an equitable response to the COVID-19 pandemic.


Subject(s)
COVID-19 , Pharmaceutical Preparations , Harm Reduction , Humans , Iran , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL